Stockscreener 앱 받기
19.28
2.68%
-0.53
시간 외 거래:
19.28
Tandem Diabetes Care Inc 주식(TNDM)의 최신 뉴스
Tandem Diabetes Care (TNDM) Down 8.9% Since Last Earnings Report: Can It Rebound? - Yahoo Finance
Artificial Pancreas Device System Market Projected To Witness - openPR
Tandem Diabetes Care Insiders Sell US$1.5m Of Stock, Possibly Signalling Caution - Simply Wall St
Tandem Diabetes Care Inc (TNDM) Stock Price Down 4.6% on Mar 26 - GuruFocus.com
3 Reasons to Sell TNDM and 1 Stock to Buy Instead - Yahoo Finance
TNDM Stock Gains on the Commercial Launch of Control-IQ+ Technology - MSN
Stifel maintains Tandem Diabetes Care stock Buy rating, $60 target By Investing.com - Investing.com UK
(TNDM) Long Term Investment Analysis - Stock Traders Daily
Tandem Diabetes Gains 45.7% in a Year: What's Driving the Stock? - MSN
Tandem Diabetes at Oppenheimer Conference: Strategic Growth Insights - Investing.com
Tandem Diabetes at Oppenheimer Conference: Strategic Growth Insights By Investing.com - Investing.com Canada
Tandem announces publication of results from trial of Control-IQ+ AID technology - Yahoo Finance
Dexcom shares 15-day CGM data; Tandem posts Type 2 pivotal data - Yahoo Finance
Tandem’s Control-IQ+ looks like a smart move for insulin-using T2D - BioWorld Online
Tandem reports A1C reduction in type 2 diabetes study By Investing.com - Investing.com South Africa
Tandem Diabetes Launches Next-Gen Automated Insulin Delivery Algorithm in U.S. - MPO-mag
Tandem reports A1C reduction in type 2 diabetes study - Investing.com India
Tandem Diabetes Care Announces NEJM Publication of Positive Pivotal Study Outcomes with Control-IQ+ AID Technology in Type 2 Diabetes - Business Wire
Automated Insulin Delivery System Helps in Type 2 Diabetes - Medscape
Tubeless Insulin Pump Market Is Booming Worldwide | Medtronic - openPR
Tandem Diabetes Care launches Control-IQ+ automated insulin delivery technology in the US - Marketscreener.com
Tandem Diabetes Care Launches New Control-IQ+ Automated Insulin Delivery Technology in the United States - Enid News & Eagle
3 Healthcare Stocks Walking a Fine Line - Yahoo Finance
Artificial Pancreas (Closed-Loop Insulin Delivery) Market - openPR
Tandem Diabetes Care (NASDAQ:TNDM) Trading Up 6.1% Following Insider Buying Activity - Defense World
Here's What Key Metrics Tell Us About Tandem Diabetes Care (TNDM) Q4 Earnings - MSN
Tandem Diabetes at Leerink Conference: Strategic Growth Amid Challenges By Investing.com - Investing.com UK
Victory Capital Management Inc. Decreases Stock Position in Tandem Diabetes Care, Inc. (NASDAQ:TNDM) - Defense World
Bank of New York Mellon Corp Purchases 4,130 Shares of Tandem Diabetes Care, Inc. (NASDAQ:TNDM) - Defense World
Tandem Diabetes Care’s SWOT analysis: stock outlook amid market challenges - Investing.com
Keybank National Association OH Has $245,000 Holdings in Tandem Diabetes Care, Inc. (NASDAQ:TNDM) - Defense World
Tandem Diabetes EVP Kyrillos purchases $190,966 in company stock By Investing.com - Investing.com South Africa
Tandem Diabetes EVP Kyrillos purchases $190,966 in company stock - Investing.com
Reasons to Hold TNDM Stock in Your Portfolio for Now - Nasdaq
Tandem Diabetes Care: A Buy Rating Backed by Growth Potential and Valuation Opportunity - TipRanks
Smartleaf Asset Management LLC Acquires 1,101 Shares of Tandem Diabetes Care, Inc. (NASDAQ:TNDM) - Defense World
Tandem Diabetes Care, Inc. to Host Earnings Call - ACCESS Newswire
Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Shares Bought by US Bancorp DE - Defense World
Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Shares Sold by Oppenheimer & Co. Inc. - Defense World
TANDEM DIABETES CARE, INC. (NASDAQ:TNDM) DEADLINE ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against Tandem Diabetes Care, Inc. - ACCESS Newswire
Tandem Diabetes Care stock hits 52-week low at $18.27 By Investing.com - Investing.com Australia
Tandem Diabetes Care stock hits 52-week low at $18.27 - Investing.com
Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Position Increased by Private Advisor Group LLC - Defense World
Morgan Stanley Downgrades Tandem Diabetes Care (NASDAQ:TNDM) to Equal Weight - Defense World
Tandem Diabetes Care (NASDAQ:TNDM) Rating Lowered to Neutral at Citigroup - Defense World
0.55%
0.10%
자본화:
|
볼륨(24시간):